thromboxanes has been researched along with Bowel Diseases, Inflammatory in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardizzone, S; Aronico, N; Balduini, A; Corazza, GR; Davì, G; Di Sabatino, A; Giuffrida, P; Guerci, M; Gurini, E; Liani, R; Malara, A; Massari, A; Santilli, F; Simeone, P; Tripaldi, R | 1 |
| Collins, CE; Rampton, DS | 1 |
1 review(s) available for thromboxanes and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Review article: thromboxanes in inflammatory bowel disease--pathogenic and therapeutic implications.
Topics: Eicosanoids; Humans; Inflammatory Bowel Diseases; Thromboxanes | 1993 |
1 other study(ies) available for thromboxanes and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatment.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; CD40 Ligand; Colitis, Ulcerative; Crohn Disease; Female; Gastrointestinal Agents; Humans; In Vitro Techniques; Inflammatory Bowel Diseases; Infliximab; Lipid Peroxidation; Male; Megakaryocytes; Middle Aged; Oxidative Stress; Platelet Activation; Thromboxanes; Tumor Necrosis Factor-alpha; Young Adult | 2016 |